For more than 30 years, physicists have wrestled with gallium’s structure in the liquid state. Now, fresh simulations offer ...

How do we know exactly what is happening at a molecular level during extremely fast processes, such as burning during ...

The presentation by Dr. Farhad Ravandi of The University of Texas MD Anderson Cancer Center will highlight emerging safety, pharmacokinetics/pharmacodynamics, and early clinical activity data for ...

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...

A team led by Prof. Shlomo Magdassi from the Institute of Chemistry and Prof. Hanna Dodiuk from Shenkar College has recently ...

SHANGHAI, China I June 9, 2025 I Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical ...

Vividion Therapeutics has secured worldwide rights for developing and commercialising VVD-214, the Werner helicase (WRN) covalent inhibitor.

A Hong Kong University of Science and Technology (HKUST) research team has developed a catalytic enantioselective type II [5 + 2] cycloaddition method to address the challenges of synthesizing chiral ...

Computational study shows how apical carbons in propellanes and pyramidanes can form hydrogen, halogen, chalcogen, pnictogen and tetrel bonds ...

One of the longstanding challenges in chemical biology has been finding ways to directly observe biological processes at work inside living cells without disturbing the action. In order to unlock new ...

In this review, we discuss both historical and recent advances (within the past 3 years) in covalent targeting of lysine and tyrosine residues in cellular proteomes using electrophilic small molecules ...